Commonwealth Biotechnologies, Inc. Provides Discussion of First Quarter 2008 Results and Market Update on New Drug Discovery Joint Venture in China

SAN DEIGO--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market:CBTE) today provided a management discussion of its first quarter 2008 financial results and a progress update on Venturepharm (Asia), CBI’s joint venture with Venturepharm Laboratories Ltd (“VPL”) (HKEX: 8225.HK).